News
Bioresponsive materials have gained prominence as innovative tools for advancing drug delivery systems, particularly in managing type 1 and type 2 diabetes mellitus. These materials respond to ...
While most of us are familiar with type 1, type 2, and even gestational diabetes, there are actually six kinds of diabetes ...
Researchers are working to launch a first-in-human clinical trial to test the approach in patients with cancer who develop ...
Social disconnection emerged as a potential driver of type 2 diabetes, revealing the hidden metabolic cost of loneliness and ...
Frequent urination could be more than just a bladder issue — it may signal rising blood sugar levels. Discover the hidden ...
SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.
Dapagliflozin plus methylcobalamin improved nerve function and glucose control in diabetic neuropathy.
The agreement enables process and analytical development activities required to advance Nimvec™ AM510 for Type 1 Diabetes toward cGMP manufacturing and first-in-human clinical trials Strengthening the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results